Stock listing
NASDAQ:DNDN Dendreon Corp Stock
Follow Dendreon Corp into a list and get an email when it puts out news.
Delisted NASDAQ:DNDN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:DNDN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Dendreon Corp on 6ix
- Decks
- 4 decks · latest May 1, 2009
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (May 2009) | Technical | 17 slides | May 1, 2009 |
| Merger or Acquisition (July 2003) | Merger or acquisition | 39 slides | Jul 7, 2003 |
| Merger or Acquisition (June 2003) | Merger or acquisition | 14 slides | Jun 10, 2003 |
| Merger or Acquisition (April 2003) | Merger or acquisition | 42 slides | Apr 15, 2003 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David C Stump Other companies: Regenxbio Inc. (Director · Since at least Oct 14, 2015); MacroGenics, Inc. (Director · Since at least Oct 9, 2013); Portola Pharmaceuticals Inc (Director · Sep 24, 2015 – Jul 2, 2020 · Past); Sunesis Pharmaceuticals Inc (Director · Jun 18, 2009 – Jun 30, 2020 · Past); Human Genome Sciences Inc (Exec. Vice President · Mar 10, 2009 – Jul 30, 2012 · Past) | Director · Jun 2, 2010 – Jan 3, 2014 · Past |
| Mark W. Frohlich Other companies: Rigel Pharmaceuticals, Inc. (Director · Since at least Mar 6, 2025); Juno Therapeutics Inc (See Remarks · Dec 18, 2014 – Feb 29, 2016 · Past) | EVP, R&D and CMO · Apr 3, 2013 – Jan 20, 2014 · Past |
| David Urdal | Director · Apr 30, 2010 – Jan 3, 2014 · Past |
Log in to ask 6ix AI your own questions about Dendreon Corp.